XML 98 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Impact of adoption of ASC 606
Common Stock
Additional Paid - In Capital
Accumulated Deficit
Accumulated Deficit
Impact of adoption of ASC 606
Accumulated Other Comprehensive Loss
Balance (in shares) at Dec. 31, 2018 13,935,666            
Balance at Dec. 31, 2018 $ 193,823            
Redeemable Convertible Preferred Stock              
Issuance of Series D redeemable convertible preferred stock, net of issuance costs of $3,934 $ 75,863            
Issuance of Series D redeemable convertible preferred stock (in shares) 5,308,129            
Accretion of redeemable convertible preferred stock to redemption value $ 13,744            
Balance (in shares) at Dec. 31, 2019 19,243,795            
Balance at Dec. 31, 2019 $ 283,430            
Balance (in shares) at Dec. 31, 2018     10,604,511        
Balance at Dec. 31, 2018 (178,750) $ 882 $ 106 $ 0 $ (178,583) $ 882 $ (273)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accretion of redeemable convertible preferred stock to redemption value (13,744)     (2,212) (11,532)    
Issuance of common stock as acquisition consideration (in shares)     173,477        
Issuance of common stock as acquisition consideration 791   $ 2 789      
Exercise of stock options (in shares)     86,634        
Exercise of stock options 343   $ 1 342      
Stock-based compensation 1,081     1,081      
Foreign currency translation adjustment 28           28
Net loss (29,853)       (29,853)    
Balance (in shares) at Dec. 31, 2019     10,864,622        
Balance at Dec. 31, 2019 (219,222)   $ 109 0 (219,086)   (245)
Redeemable Convertible Preferred Stock              
Accretion of redeemable convertible preferred stock to redemption value $ 15,095            
Balance (in shares) at Dec. 31, 2020 19,243,795            
Balance at Dec. 31, 2020 $ 298,525            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accretion of redeemable convertible preferred stock to redemption value (15,095)     (2,851) (12,244)    
Exercise of stock options (in shares)     511,426        
Exercise of stock options 2,010   $ 5 2,005      
Stock-based compensation 846     846      
Foreign currency translation adjustment 43           43
Net loss $ (12,528)       (12,528)    
Balance (in shares) at Dec. 31, 2020 11,376,048   11,376,048        
Balance at Dec. 31, 2020 $ (243,946)   $ 114 0 (243,858)   (202)
Redeemable Convertible Preferred Stock              
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares) (19,243,795)            
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering $ (305,586)            
Accretion of redeemable convertible preferred stock to redemption value $ 7,061            
Balance (in shares) at Dec. 31, 2021 0            
Balance at Dec. 31, 2021 $ 0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accretion of redeemable convertible preferred stock to redemption value (7,061)     (3,400) (3,661)    
Issuance of common stock as acquisition consideration (in shares)     45,152        
Issuance of common stock as acquisition consideration $ 767   $ 1 766      
Exercise of stock options (in shares) 677,569   677,569        
Exercise of stock options $ 2,729   $ 7 2,722      
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares)     19,243,795        
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering 305,586   $ 192 305,394      
Issuance of common stock in connection with initial public offering (in shares)     6,612,500        
Issuance of common stock in connection with initial public offering, net of issuance costs of $14,762 $ 117,488   $ 66 117,422      
Issuance of common stock for cashless exercise of warrants (in shares)     35,665        
Vested restricted stock units converted to common shares (in shares) 800            
Stock-based compensation $ 2,865     2,865      
Foreign currency translation adjustment (27)           (27)
Net loss $ (20,963)       (20,963)    
Balance (in shares) at Dec. 31, 2021 37,991,529   37,991,529        
Balance at Dec. 31, 2021 $ 157,438   $ 380 $ 425,769 $ (268,482)   $ (229)